MENS - Jyong Biotech Limited Qarzning balans kapitallashuviga nisbati

Jyong Biotech Limited (MENS) grafik logotipi

Jyong Biotech Ltd (MENS) bevosita raqobatni minimallashtiruvchi, patent himoyasidagi noyob o'simliklar asosidagi dori vositalarini ishlab chiqadi. Osiyoda profilaktik terapiyaga bo'lgan qiziqish erkaklar salomatligi mahsulotlariga bo'lgan talabning ortishiga turtki bo'lmoqda. Shu bilan birga, biznesning muvaffaqiyati testlardan o'tishga bog'liq bo'lib, joriy ko'rsatkich 0.00 darajasida turibdi. Quyidagi narxlar grafigi murakkab tadqiqotlarda sanoat gigantlaridan ustunlik qilish qobiliyatiga bog'liq bo'lgan aktivning dinamikasini aks ettiradi.

MENS (Jyong Bio) Qarzning balans qiymatiga nisbati tarixi 18.06.2025dan 28.10.2026gacha

Jyong Biotech Limited (MENS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Jyong Biotech Ltd|MENS - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Jyong Bio|MENS - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Jyong Biotech|MENS - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati jyongbio.com|MENS - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning xususiy kapitalga nisbati Jyong Biotech Ltd|MENS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Jyong Biotech Corp|MENS - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans qiymatiga nisbati Jyong Bio|MENS - Uzoq muddatli majburiyatlar miqdori|Kompaniyaning qisqa muddatli qarzlari Jyong Biotech
Kompaniyaning barcha koʻrsatkichlari tahlili:MENS Jyong Biotech Ltd
Jyong Biotech Corp asosiy tovari

Ushbu koeffitsient qarzdorlikning kapitalga nisbatini o'lchaydi, bu esa 0.00 ning joriy qiymatida moliyaviy leveraj va defolt xavfini baholash imkonini beradi. Jyong Biotech Ltd (MENS) kompaniyasining umumiy qarzdorlikning kapitalga nisbatini tahlil qilish stress-testlar uchun juda muhimdir, chunki uzoq muddatli klinik dori sinovlari dori sintezini avtomatlashtirish orqali yolg'iz ta'minlab bo'lmaydigan barqaror moliyalashtirishni talab qiladi.

Jyong Biotech Ltd raqobatchilari

Balans kapitallashuviga qarzlar HLN (Haleon plc)|kenvue.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Verona Pharma (VRNA)|LGND: Qarzning sof aktivlarga nisbati|AMRX (Amneal Pharmaceuticals Inc) - Qarzning balans kapitallashuviga nisbati|Perrigo Corp (PRGO) - Qarzning balans qiymatiga nisbati|ALVO (Alvotech) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar liquidia.com (LQDA)|Galapagos (GLPG) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati ANIP (ANI Pharmaceuticals Inc)|MNKD: Qarzning balans kapitallashuviga nisbati|AMPH - Balans qiymatiga qarzlar|Qarzning balans qiymatiga nisbati Pacira BioSciences PCRX|SPRY - Qarzning balans kapitaliga nisbati|Balans kapitallashuviga qarzlar Theravance Biopharma, Inc. TBPH|Aquestive Therapeutics Inc (AQST) - Qarzning sof aktivlarga nisbati|Balans kapitallashuviga qarzlar SCPH (scPharmaceuticals, Inc.)|Balans qiymatiga qarzlar TECX|Tonix Pharmaceuticals (TNXP) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati SXTC (sxtchina.com)|Qarzning balans kapitallashuviga nisbati Eupraxia Pharmaceuticals Inc. (EPRX)|BHST - Qarzning balans kapitaliga nisbati|EXOZ (Invizyne Technologies, Inc.) - Qarzning balans qiymatiga nisbati|ORMP: Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati ENTX|HYFT (ipatherapeutics.com) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati ABVC BioPharma, Inc. (ABVC)|Qarzning balans qiymatiga nisbati Cumberland Pharmaceuticals Inc|QNTM: Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati FibroGen Corporation FGEN|Qarzning balans qiymatiga nisbati Telomir Pharmaceuticals|Qarzning sof aktivlarga nisbati Rani Therapeutics Holdings RANI|SNYR - Balans kapitallashuviga qarzlar|RLYB - Qarzning balans kapitallashuviga nisbati|lexariabioscience.com - Balans kapitallashuviga qarzlar|PULM (Pulmatrix Corporation) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati PTHL (Pheton Holdings Limited)|Balans qiymatiga qarzlar Aptorum (APM)|Qarzning balans qiymatiga nisbati Lyra Therapeutics|Qarzning balans kapitaliga nisbati Impact BioMedical, Inc. (IBO)|TNFA: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar cbdMD Inc. YCBD|PRFX: Balans kapitallashuviga qarzlar|CYTO - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Lipella Pharmaceuticals, Inc. LIPO|Qarzning sof aktivlarga nisbati OptiNose Inc|PIRS - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati PROC|Qarzning balans kapitallashuviga nisbati Petros Pharmaceuticals (PTPI)|Qarzning balans kapitallashuviga nisbati qlsyy.net QLI|Qarzning balans qiymatiga nisbati ACELYRIN (SLRN)|Qarzning balans kapitaliga nisbati TFF Pharmaceuticals Inc. TFFP